These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10149900)

  • 1. What criteria does the FDA use to evaluate new technology?
    Reamer LA
    J Invasive Cardiol; 1992 Mar; 4(2):83-8. PubMed ID: 10149900
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in government regulation of device research.
    Acharya A
    J Invasive Cardiol; 1993 Mar; 5(2):69-73. PubMed ID: 10148627
    [No Abstract]   [Full Text] [Related]  

  • 3. Should the FDA control medical services?
    Beall A
    Ariz Med; 1968 Aug; 25(8):720-1. PubMed ID: 5674277
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.
    Bramstedt KA
    Clin Invest Med; 2004 Jun; 27(3):129-34. PubMed ID: 15305804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA insists on more women in drug trials.
    Josefson D
    BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
    Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA tightens human oversight.
    Dove A
    Nat Med; 2001 Jun; 7(6):646. PubMed ID: 11385485
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA uneasy about placebo revision.
    Hollon T
    Nat Med; 2001 Jan; 7(1):7. PubMed ID: 11135592
    [No Abstract]   [Full Text] [Related]  

  • 14. [First-in-human clinical trials: comparison of EMEA and FDA guidelines].
    Hernández-López C
    Med Clin (Barc); 2009 Jan; 132(1):30-4. PubMed ID: 19174063
    [No Abstract]   [Full Text] [Related]  

  • 15. International Conference on Harmonisation; draft guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products--FDA. Notice.
    Fed Regist; 1998 Jun; 63(110):31506-13. PubMed ID: 10180131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA slow to encourage lupus drugs.
    Webber D
    Nat Biotechnol; 1999 Apr; 17(4):319. PubMed ID: 10207867
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.